NEWS
View news from our Featured Companies.
NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology’s Blood Journal
Abstract from 2023 American Society of Hematology (ASH) MeetingData demonstrates differentiated profile from DARZALEX® (daratumumab) with best-in-class potential, supports initiation of clinical trials in 2024NAYA expects to close its previously announced merger...
NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK™ Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therapies
NAYA Biosciences and ONK Therapeutics to assess proof-of-concept and establish activity and feasibility of the combination of NAYA's FLEX-NK™ bispecific antibodies and ONK's optimally engineered natural killer (NK) cells for the treatment of cancerPartnership...
Precision Optics Enters into Production and Technology Licensing Agreement for Single-Use Cystoscopy Robotic Surgery Program
GARDNER, Mass., Dec. 4, 2023 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense / aerospace industries, today announced it has signed a production and technology license...
SenesTech’s ContraPest® Registered for Use in Puerto Rico to Combat Rat Infestations
PHOENIX, Dec. 4, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the leader in fertility control to manage animal pest populations, today announces its ContraPest® products have been registered for sale and immediate use...
Cadrenal Therapeutics to Present at the NobleCon 19 Conference on December 4, 2023
PONTE VEDRA, Fla., Nov. 30, 2023 -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes and deaths due to blood...
Reviva Pharmaceuticals to Participate in The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
CUPERTINO, Calif., Nov. 30, 2023 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023
Webcasted presentation to take place at 1:10pm ETDENVER, CO / November 30, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that its CEO, Josh Disbrow, will be...
Zoomd Technologies Reports Third Quarter 2023 Financial Results, Driven by Strong Adjusted EBITDA Growth
Conference call will be held on November 30, 2023, at 11AM ET. VANCOUVER, British Columbia, Nov. 30, 2023 /CNW/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing...
IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes
WINTER SPRING, Fla., Nov. 30, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) was recently named on Forbes' latest list of America's Most Successful Small-Cap Companies for 2024. Iradimed is a leader in the development of innovative magnetic resonance...
A Milestone Phase I Randomized, Double-Blind Clinical Trial Demonstrates High-Dose Niagen®, Patented Nicotinamide Riboside (NR), Supplementation Induces a Potent NAD+ Response and Is Associated With Mild Improvement in Parkinson’s Disease (PD)
Building on a growing body of research showcasing NR as a potential therapeutic strategy for PD, this is the first clinical study to showcase the safety, tolerability, and beneficial metabolic effects of high-dose NR at 3,000 mg per day LOS ANGELES - ChromaDex Corp....
SenesTech, Inc. Announces Closing of $5.0 Million Public Offering
PHOENIX, Nov. 29, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com), the leader in fertility control to manage animal pest populations, today announced the closing of its previously announced public offering of 3,846,154 shares...
InfuSystem to Present at Sidoti Small-Cap Virtual Conference on December 6, 2023
ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced...
Jewett-Cameron Announces Fiscal 2023 Financial Results
NORTH PLAINS, Ore., Nov. 28, 2023 -- Jewett-Cameron Trading Company Ltd. (NASDAQ: JCTCF) today reported financial results for its fourth quarter and fiscal year ended August 31, 2023. For the fiscal year ended August 31, 2023, Jewett-Cameron had sales of $54.3 million...
INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders’ Equity Requirement
SARASOTA, Fla., Nov. 28, 2023 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services company focused on expanding access to advanced fertility treatment worldwide with its INVOcell® medical device and the intravaginal culture...
SenesTech, Inc. Announces Pricing of $5.0 Million Public Offering
PHOENIX, Nov. 27, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the leader in fertility control to manage animal pest populations, today announced the pricing of a public offering of 3,846,154 shares of its common stock (or...
SenesTech Launches EVOLVE Soft Bait Fertility Solution in California-based Ace Hardware Franchise Locations
PHOENIX, Nov. 27, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the leader in fertility control to manage animal pest populations, today announced the launch of Evolve™ Soft Bait ("Evolve") at Ace Hardware franchise...
Zoomd to Report Third Quarter 2023 Financial Results on November 30, 2023
Conference call to be conducted on November 30, 2023, at 11 a.m. ET. VANCOUVER, BC, Nov. 27, 2023 /CNW/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology...
Reviva Announces Closing of $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
CUPERTINO, Calif., Nov. 20, 2023 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
NeurAxis Reports Third Quarter 2023 Financial Results
CARMEL, Ind., Nov. 20, 2023 -- NeurAxis, Inc. (NYSE American: NRXS) ("NeurAxis" or the "Company"), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today reported financial...
SenesTech Expands Distribution with DIY Pest Control Through Initial Stocking Order of EVOLVE Soft Bait Fertility Control Product
PHOENIX, Nov. 20, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the leader in fertility control to manage animal pest populations, today announced that it has renewed and expanded its distribution with DIY Pest Control with...
Aquafil Announces Main Goals and Financial Targets Presentation
Management Presentation to be webcast live on November 21, 2023 at 2:30PM CET/8:30AM Eastern Standard TimeARCO, Italy, Nov. 17, 2023 -- Aquafil SpA (ECNLF:OTCQX - ECNL:IM), based in Arco (TN) Italy, pioneer of circular economy, today announced that it will be hosting...
Precision Optics Receives Initial Purchase Order Against $1.4 Million Development Program
GARDNER, Mass., Nov. 16, 2023 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense / aerospace industries, today announced the receipt of initial purchase orders towards a...
Reviva Announces $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
CUPERTINO, Calif., Nov. 16, 2023 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
SenesTech Announces Reverse Stock Split
Common Stock Will Begin Trading on a Split-Adjusted Basis on November 17, 2023 PHOENIX, Nov. 15, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com), the leader in fertility control to manage animal pest populations, today...
NeurAxis Announces CareFirst BCBS Policy Coverage
CARMEL, Ind., Nov. 15, 2023 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced receipt of...